$19.65 0.00 (0%)
2/10/2012 3:59 PM

Insulet Corp (NASDAQ:PODD)

CAPS Rating: 1 out of 5

Dvlp,mftr,mkt insulin infusion system for diabetes

Results 1 - 11 of 11

Recs

0
Member Avatar drfager22 (31.61) Submitted: 1/15/2012 6:55:36 PM : Outperform Start Price: $19.07 PODD Score: -0.95

This medical device company has huge upside beyond diabetes in my professional specialty, drug delivery.

Recs

0
Member Avatar derbygirl (23.99) Submitted: 11/19/2010 9:09:32 AM : Outperform Start Price: $12.80 PODD Score: +41.45

Insulet Corporation has a popular "no wires" pump. They are also partnering in research with Dexcom for a closed loop diabetes management system. Recent FDA requirements on those studies have temporarily hurt them, but IMHO they will bounce back.

Recs

1
Member Avatar BACnumber1 (< 20) Submitted: 2/13/2010 12:35:19 PM : Outperform Start Price: $15.11 PODD Score: +6.62

Watch Supersize Me. Once you watch the whole movie, you'll know why this stock is poised for greatness along with any other insulin provider

Recs

0
Member Avatar HedgeFund007 (49.87) Submitted: 2/12/2010 12:37:00 PM : Underperform Start Price: $15.11 PODD Score: -5.30

Ohh great! Another company out to save the world from diabetes..

PUH LEEZE!

Recs

0
Member Avatar cpalerm (45.32) Submitted: 4/4/2009 1:13:51 PM : Underperform Start Price: $4.42 PODD Score: -281.73

While they have a very nice product it has some design 'features' which might lead to trouble. Each pod (the actual pump) works for only 3 days and is thrown away after that. This means 122 pods per patient per year; scaling up production to be able to serve any significant portion of the US market, much less the world market, is a huge endeavor. This is most likely why they have not gone ahead into offering the pump for use in the delivery of other drugs.
There are other related issues to their product that makes it harder to sustain market share, particularly in times like these, with many people loosing their health insurance and therefore not being able to keep purchasing the pumps.

Recs

0
Member Avatar billwdude (93.01) Submitted: 11/14/2008 9:38:46 PM : Outperform Start Price: $4.29 PODD Score: +298.46

New VP Bill Arthur is a driving force has done nothing but succeed in this business for 20 years.

Recs

1
Member Avatar delos2 (< 20) Submitted: 8/11/2008 6:17:09 PM : Underperform Start Price: $14.97 PODD Score: -24.84

Not a market guy, but a manufacturing guy. Insulet was my account up until last year when the printed circuit board company I worked for finally gave up to offshore pressure. I knew a lot of these guys and I am amazed this company has not taken off like a rocket. Never opened a Schwab account before but did for this group and closed it when I thought they couldn't figure out how to get out of their own way. One of life's disapointments. Insulet needs to figure out how to stop spending and start making money. A top notch product I know well. Good luck - when the price point is back in the $12's will take another look. There were a whole list of meds this pump was slated to dispense.

Recs

1
Member Avatar matkow (< 20) Submitted: 7/23/2008 2:58:18 PM : Outperform Start Price: $15.64 PODD Score: +17.36

I use there product and it is far superior to all of the other insulin pumps on the market. I have also seen that they are teaming up with several other companies to produce new products such as a combined pump and CGM that may combine the insulin pump and the CGM sensor so you only have to have one thing stuck on your body. That would be a relief for people like me who don't want to stick two things to their bodes.

Also I think that the innovative thinking that made them the first tubeless pump will help guide them to make more improvements to their product.

I think the worst case scenario is they get bought by some larger company like Medtronic or Abbott.

Recs

0
Member Avatar thedukie (< 20) Submitted: 6/25/2008 9:38:20 AM : Underperform Start Price: $16.27 PODD Score: -15.95

Medtronic will have competitive product in the future, and insulet has production issues and is burning through a lot of cash.

Recs

0
Member Avatar BarelyMarginal (66.62) Submitted: 2/7/2008 10:41:37 AM : Outperform Start Price: $18.34 PODD Score: +1.62

Newly on the market medical device maker with very good buzz and decent returns.

Recs

0
Member Avatar swestlak (< 20) Submitted: 2/5/2008 1:46:03 PM : Outperform Start Price: $17.98 PODD Score: +5.28

Great market space and product combined with solid management. What diabetic wouldnt want their product?

Results 1 - 11 of 11

Featured Broker Partners


Advertisement